145 related articles for article (PubMed ID: 34801711)
1. Serum β-HCG Level in Women Diagnosed as Having Retained Products Of Conception: A Prospective Cohort Study.
Smorgick N; Segal H; Eisenberg N; Dovev MN; Dvash S; Rabinovich I
J Minim Invasive Gynecol; 2022 Mar; 29(3):424-428. PubMed ID: 34801711
[TBL] [Abstract][Full Text] [Related]
2. Office hysteroscopy in removing retained products of conception - a highly successful approach with minimal complications.
Jakopič Maček K; Blaganje M; Kenda Šuster N; Drusany Starič K; Kobal B
J Obstet Gynaecol; 2020 Nov; 40(8):1122-1126. PubMed ID: 31793362
[TBL] [Abstract][Full Text] [Related]
3. Office Operative Hysteroscopy for the Management of Retained Products of Conception.
Mohr-Sasson A; Gur T; Meyer R; Mashiach R; Stockheim D
Reprod Sci; 2022 Mar; 29(3):761-767. PubMed ID: 35020188
[TBL] [Abstract][Full Text] [Related]
4. Does the time interval between the diagnosis to hysteroscopic evacuation of retained products of conception affect reproductive outcome?
Tarasov M; Burke YZ; Stockheim D; Orvieto R; Cohen SB
Arch Gynecol Obstet; 2020 Dec; 302(6):1523-1528. PubMed ID: 32785781
[TBL] [Abstract][Full Text] [Related]
5. Two-step hysteroscopy for management of morbidly adherent retained products of conception.
Smorgick N; Rabinovitch I; Levinsohn-Tavor O; Maymon R; Vaknin Z; Pansky M
Arch Gynecol Obstet; 2019 Sep; 300(3):669-674. PubMed ID: 31321494
[TBL] [Abstract][Full Text] [Related]
6. Hysteroscopic removal of retained products of conception following first trimester medical abortion.
Smorgick N; Levinsohn-Tavor O; Ben-Ami I; Maymon R; Pansky M; Vaknin Z
Gynecol Minim Invasive Ther; 2017; 6(4):183-185. PubMed ID: 30254910
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound for diagnosis of postpartum retained products of conception-How accurate we are?
Yagur Y; Jurman L; Weitzner O; Arbib N; Markovitch O; Klein Z; Daykan Y; Schonman R
BMC Pregnancy Childbirth; 2023 Aug; 23(1):572. PubMed ID: 37563560
[TBL] [Abstract][Full Text] [Related]
8. Retained products of conception: What is the risk for recurrence on subsequent pregnancies?
Smorgick N; Mittler A; Ben-Ami I; Maymon R; Vaknin Z; Pansky M
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():1-5. PubMed ID: 29525517
[TBL] [Abstract][Full Text] [Related]
9. Is Hysteroscopy the Best Surgical Approach for Removal of Retained Products of Conception Following Surgical Termination of Pregnancy?
Smorgick N; Kostin S; Tzur T; Levinsohn-Tavor O; Maymon R; Vaknin Z
J Obstet Gynaecol Can; 2020 Aug; 42(8):953-956. PubMed ID: 32386964
[TBL] [Abstract][Full Text] [Related]
10. Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors?
Barel O; Krakov A; Pansky M; Vaknin Z; Halperin R; Smorgick N
Fertil Steril; 2015 Mar; 103(3):775-9. PubMed ID: 25527235
[TBL] [Abstract][Full Text] [Related]
11. Postpartum retained products of conception: Retrospective analysis of the association with third stage of labor placental complications.
Smorgick N; Ayashi N; Levinsohn-Tavor O; Wiener Y; Betser M; Maymon R
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():108-111. PubMed ID: 30682599
[TBL] [Abstract][Full Text] [Related]
12. Conservative management for retained products of conception after less than 22 weeks of gestation.
Shitanaka S; Chigusa Y; Kawahara S; Kawasaki K; Mogami H; Mandai M; Kondoh E
J Obstet Gynaecol Res; 2020 Oct; 46(10):1982-1987. PubMed ID: 32761752
[TBL] [Abstract][Full Text] [Related]
13. Pregnancies Following Hysteroscopic Removal of Retained Products of Conception after Delivery Versus Abortion.
Ganer Herman H; Kogan Z; Tairy D; Ben Zvi M; Kerner R; Ginath S; Bar J; Sagiv R
Gynecol Obstet Invest; 2018; 83(6):586-592. PubMed ID: 29945122
[TBL] [Abstract][Full Text] [Related]
14. Operative hysteroscopy for retained products of conception: Efficacy and subsequent fertility.
Capmas P; Lobersztajn A; Duminil L; Barral T; Pourcelot AG; Fernandez H
J Gynecol Obstet Hum Reprod; 2019 Mar; 48(3):151-154. PubMed ID: 30553048
[TBL] [Abstract][Full Text] [Related]
15. See-and-treat in-office hysteroscopy versus operative hysteroscopy for the treatment of retained products of conception: A retrospective study.
Raz N; Sigal E; Gonzalez Arjona F; Calidona C; Garzon S; Uccella S; Laganà AS; Haimovich S
J Obstet Gynaecol Res; 2022 Sep; 48(9):2459-2465. PubMed ID: 35698805
[TBL] [Abstract][Full Text] [Related]
16. Routine ultrasonographic and hysteroscopic evaluations of women undergoing postpartum manual removal of placenta: a retrospective cohort study.
Namazov A; Elkabetz N; Ivshin E; Zohav E; Shenhav S; Kapustian V; Anteby EY; Gemer O
Arch Gynecol Obstet; 2020 Mar; 301(3):715-719. PubMed ID: 31950246
[TBL] [Abstract][Full Text] [Related]
17. Hysteroscopy-assisted suction curettage for early pregnancy loss: does it reduce retained products of conception and postoperative intrauterine adhesions?
Moore O; Tzur T; Vaknin Z; Rabbi ML; Smorgick N
Arch Gynecol Obstet; 2024 Jan; 309(1):205-210. PubMed ID: 37782418
[TBL] [Abstract][Full Text] [Related]
18. A novel method for office aspiration curettage in cases of retained products of conception: A randomized controlled trial.
Pomeranz M; Goren Gepstein N; Ovadia M; Klein Z; Daykan Y; Schonman R; Arbib N
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2076-2081. PubMed ID: 34467531
[TBL] [Abstract][Full Text] [Related]
19. [Research on the trend of the decrease of human chorionic gonadotropin in the treatment of cesarean scar pregnancy by different surgical treatments].
Hu QF; Li CD; Chen SW; Li J
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(29):2332-5. PubMed ID: 27524191
[TBL] [Abstract][Full Text] [Related]
20. Reproductive and obstetric outcomes following operative hysteroscopy for treatment of retained products of conception.
Chill HH; Safrai M; Karavani G; Cohen A; Alexandroni H; Bahar R; Shushan A
Minerva Obstet Gynecol; 2021 Aug; 73(4):494-499. PubMed ID: 34319060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
